The world’s leading manufacturer of laboratory glass and life science packaging materials, DWK Life Sciences, announces the closing of the acquisition of Müller + Müller on September 30st, 2020. Müller + Müller is one of the leading German manufacturers of primary packaging materials made of tubular glass for the pharmaceutical industry. While now being part of the DWK Life Sciences group, Müller + Müller will continue to serve its customers under the same name and will continue to be headed by Managing Director Florian Müller-Stauch.
Müller + Müller is based in Holzminden in Lower Saxony, Germany, and currently employs 135 staff. The family-run company is a key player in the manufacture of vials and has a long history of over 95 years. Thanks to its state-of-the-art technology and continuous process optimisation, Müller + Müller meets the highest quality requirements for pharmaceutical packaging. Every year approx. 300 million glass type I vials are produced at its Holzminden site in accordance with GMP guidelines. Type I borosilicate glass is an excellent material for storing vaccines as the glass is virtually inert. This means that the container glass does not react with its contents and thus represents the standard in vaccine packaging.
DWK Life Sciences is a portfolio company of One Equity Partners, a middle market private equity firm that builds market-leading companies by identifying and executing transformative business combinations and partnering with management teams to provide operational support to accelerate growth.
For more information, please visit their website here.